June 18, 2014—The Health Resources and Services Administration announced this morning that it stands by its interpretation of the 340B orphan drug exclusion that lets critical access hospitals, sole community hospitals, rural referral centers, and free-standing cancer hospitals access 340B pricing on orphan drugs when they "are used for any indication other than treating the … [Read more...]
HHS Won’t Ask Judge to Take Second Look at 340B Orphan Drug Rule
Government might appeal and/or issue "interpretative" rule or guidanceJune 13, 2014—The Department of Health and Human Services has opted not to ask a federal district judge to uphold its 340B orphan drug exclusion regulation as an "interpretative" rather than "legislative" rule. … [Read more...]